These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19491086)

  • 61. The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer.
    Takabatake D; Kajiwara Y; Ohtani S; Itano Y; Yamamoto M; Kubo S; Ikeda M; Takahashi M; Hara F; Aogi K; Ohsumi S; Ogasawara Y; Nishiyama Y; Hikino H; Matsuoka K; Takahashi Y; Shien T; Taira N; Doihara H
    Breast Cancer; 2018 Nov; 25(6):717-722. PubMed ID: 29948957
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Examination of the safety of docetaxel/cyclophosphamide combination therapy for advanced recurrent breast cancer].
    Yoneyama K; Koshida Y; Toriumi F; Murayama T; Toeda H; Imazu Y; Motegi K; Akamatsu H; Ohyama R
    Gan To Kagaku Ryoho; 2006 Oct; 33(10):1525-7. PubMed ID: 17033252
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Analysis of the Side Effects of Docetaxel with Cyclophosphamide (TC Therapy)].
    Imanishi S; Koyama H; Matsui C
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):709-11. PubMed ID: 26199242
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Toxicity profile differences of adjuvant docetaxel/cyclophosphamide (TC) between Asian and Caucasian breast cancer patients.
    Chow LWC; Biganzoli L; Leo AD; Kuroi K; Han HS; Patel J; Huang CS; Lu YS; Zhu L; Chow CYC; Loo WTY; Glück S; Toi M
    Asia Pac J Clin Oncol; 2017 Dec; 13(6):372-378. PubMed ID: 28371190
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Effect of oral dexamethasone given 24 hours previously on docetaxel-induced edema: a retrospective study].
    Kato A; Masuda N; Makihara K; Ueno H; Hirohata K; Yamauchi K; Yasojima H; Mizutani M; Yamamura J; Komori K
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):211-4. PubMed ID: 24743199
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prevalence of excessive tearing in women with early breast cancer receiving adjuvant docetaxel-based chemotherapy.
    Chan A; Su C; de Boer RH; Gajdatsy A
    J Clin Oncol; 2013 Jun; 31(17):2123-7. PubMed ID: 23650421
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [A case of breast cancer with chronic renal failure successfully treated with TC therapy as adjuvant chemotherapy].
    Oshiro C; Arai T; Kamigaki S; Matsuura M
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):265-7. PubMed ID: 22333640
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Comparison of adverse events following injection of original or generic docetaxel for the treatment of breast cancer.
    Tagawa N; Sugiyama E; Tajima M; Sasaki Y; Nakamura S; Okuyama H; Shimizu H; Sato VH; Sasaki T; Sato H
    Cancer Chemother Pharmacol; 2017 Oct; 80(4):841-849. PubMed ID: 28864856
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Side effects of standard adjuvant and neoadjuvant chemotherapy regimens according to age groups in primary breast cancer.
    Reinisch M; von Minckwitz G; Harbeck N; Janni W; Kümmel S; Kaufmann M; Elling D; Nekljudova V; Loibl S
    Breast Care (Basel); 2013 Mar; 8(1):60-6. PubMed ID: 24715845
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Perioperative Docetaxel-induced Limb Edema on Health-related Quality of Life in Patients with Early-stage Breast Cancer: A Prospective Observational Study.
    Matsumoto K; Morimoto Y; Wakatsuki J; Sakuma D; Mukouyama K; Inoue M; Kimura A; Hirosawa I; Watanabe K
    Yakugaku Zasshi; 2024; 144(6):685-690. PubMed ID: 38825477
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Comparative study of adjuvant chemotherapeutic efficacy of docetaxel plus cyclophosphamide and doxorubicin plus cyclophosphamide in female breast cancer.
    Adeel M; Asif M; Faisal MN; Chaudary MH; Malik MS; Khalid M
    Cancer Manag Res; 2019; 11():727-739. PubMed ID: 30697066
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Comparative Safety Study of Original and Generic Docetaxel without Alcohol in the Treatment of Breast Cancer].
    Hara M; Eto T; Ijichi H; Nakamura Y; Koga C; Tajiri W; Okamoto M; Tokunaga E; Misumi N
    Gan To Kagaku Ryoho; 2022 Dec; 49(12):1355-1359. PubMed ID: 36539249
    [TBL] [Abstract][Full Text] [Related]  

  • 73. What is the Japanese consensus on adjuvant chemotherapy in breast cancer?
    Saeki T
    Breast Cancer; 2003; 10(1):15-20. PubMed ID: 12525758
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Breast Cancer Version 2.2015.
    Gradishar WJ; Anderson BO; Balassanian R; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goetz M; Goldstein LJ; Hudis CA; Isakoff SJ; Marcom PK; Mayer IA; McCormick B; Moran M; Patel SA; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith KL; Smith ML; Soliman H; Somlo G; Telli M; Ward JH; Shead DA; Kumar R
    J Natl Compr Canc Netw; 2015 Apr; 13(4):448-75. PubMed ID: 25870381
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Breast cancer version 3.2014.
    Gradishar WJ; Anderson BO; Blair SL; Burstein HJ; Cyr A; Elias AD; Farrar WB; Forero A; Giordano SH; Goldstein LJ; Hayes DF; Hudis CA; Isakoff SJ; Ljung BM; Marcom PK; Mayer IA; McCormick B; Miller RS; Pegram M; Pierce LJ; Reed EC; Salerno KE; Schwartzberg LS; Smith ML; Soliman H; Somlo G; Ward JH; Wolff AC; Zellars R; Shead DA; Kumar R;
    J Natl Compr Canc Netw; 2014 Apr; 12(4):542-90. PubMed ID: 24717572
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Clinically relevant gene signatures provide independent prognostic information in older breast cancer patients.
    Castresana-Aguirre M; Johansson A; Matikas A; Foukakis T; Lindström LS; Tobin NP
    Breast Cancer Res; 2024 Mar; 26(1):38. PubMed ID: 38454481
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The Comparative Safety of Epirubicin and Cyclophosphamide versus Docetaxel and Cyclophosphamide in Lymph Node-Negative, HR-Positive, HER2-Negative Breast Cancer (ELEGANT): A Randomized Trial.
    Liu D; Wu J; Lin C; Ding S; Lu S; Fang Y; Huang J; Hong J; Gao W; Zhu S; Chen X; Huang O; He J; Chen W; Li Y; Shen K; Zhu L
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804991
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Evaluation of a novel medical device for pegfilgrastim administration.
    Aruga T; Doihara H; Yanagita Y; Ishida T; Yamashita T; Uehara K; Taira T; Tsurutani J; Takeshita T; Tsuyuki S; Kaneko K; Ohtake T; Yamaguchi Y; Hara Y; Saji S
    Cancer Sci; 2022 May; 113(5):1763-1770. PubMed ID: 35293085
    [TBL] [Abstract][Full Text] [Related]  

  • 79. "Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia".
    Bajpai J; Kagwade S; Chandrasekharan A; Dandekar S; Kanan S; Kembhavi Y; Ghosh J; Banavali SD; Gupta S
    Breast; 2020 Feb; 49():187-193. PubMed ID: 31865282
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Early neutropenia on day 8 treated with adjuvant Docetaxel-based chemotherapy in early breast cancer patients: Putative mechanisms within the neutrophil pool system.
    Furuya Y
    PLoS One; 2019; 14(4):e0215576. PubMed ID: 30998754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.